GSK (GLAXF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GSK

    OTC: GLAXF · Real-Time Price · USD
    19.95
    0.31 (1.58%)
    At close: Aug 29, 2025, 1:21 PM
    19.64
    -1.58%
    After-hours: Aug 27, 2025, 08:00 PM EDT

    GSK Cash Flow Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 2.95B 5.31B 4.92B 5.1B
    Depreciation & Amortization
    		 2.55B 2.29B 2.3B 2.52B
    Stock-Based Compensation
    		 344M 307M 346M 343M
    Other Working Capital
    		 2.04B 724M 662M 435M
    Other Non-Cash Items
    		 -1.38B -777M 803M 756M
    Deferred Income Tax
    		 n/a n/a -1.24B -318M
    Change in Working Capital
    		 2.09B -364M 271M -473M
    Operating Cash Flow
    		 6.55B 6.77B 7.4B 7.95B
    Capital Expenditures
    		 -2.98B -2.34B -2.26B -2.93B
    Cash Acquisitions
    		 1.37B -1.38B -3.14B 185M
    Purchase of Investments
    		 n/a n/a -703M 1.76B
    Sales Maturities Of Investments
    		 21M 72M 1M 18M
    Other Investing Acitivies
    		 -1.22B 1.03B -2.68B -808M
    Investing Cash Flow
    		 -1.23B -1.59B -8.77B -1.78B
    Debt Repayment
    		 -1.17B -2.37B -4.62B -2B
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 -2.44B -2.25B -3.47B -4B
    Other Financial Acitivies
    		 -1.14B -1.03B 8.89B -1.61B
    Financial Cash Flow
    		 -4.73B -5.64B 823M -7.59B
    Net Cash Flow
    		 545M -567M -394M -1.44B
    Free Cash Flow
    		 3.57B 4.42B 5.14B 5.02B

    Add to Watchlist